Retatrutide remains investigational and has not received FDA approval for any indication as of May 2026
Side Effects and Tolerability The side-effect profiles are broadly similar because both medications activate the same receptor pathways
CrossRef Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals Mengjie Hu, Huawei Wang, Zixuan Mei, Cheng Gong, Lan Lan, Zixuan Ma, Binhao Zhang, Haomiao Fan, Yuqing Zhang, He Wang, Wanshun Chun, Dingyu Pan, Jianliang Zhou, Zhen Li Metabolism and Target Organ Damage .2026;[Epub] CrossRef Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunctionassociated steatotic liver disease (MASLD) without cirrhosis Hao-Chien Hung, Po-Jung Hsu, Yin Lai, Wei-Chen Lee, Chen-Fang Lee Annals of Hepatology .2026
) Modulates Gut Peptide Hormone Secretion and Reduces Energy Intake in Healthy-Weight Men: A Randomized, Crossover Clinical Trial
Retatrutide degrades under UV exposure
